Ritbune Prakobkit, MD, William Churk-Nam Auyeung, MD

Slides:

Advertisements

Similar presentations

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Advertisements

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Jeffrey Bradley, MD Journal of Thoracic Oncology

Ground-Glass Centrilobular Nodules on Multidetector CT Scan

Sequential Immunologic Reactions after Suspension of Nivolumab Treatment in Lung Adenocarcinoma Patient Hiromichi Shirasu, MD, Akira Ono, MD, Toshiaki.

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease Eisaku.

Next Generation Sequencing Uncovers Potential Genetic Driver Mutations of Malignant Pulmonary Granular Cell Tumor Song Xu, Qingchun Zhao, Sen Wei, Yi.

Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD Journal of Thoracic Oncology

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib Nobukazu Agatsuma, MD Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib Nobukazu Agatsuma, MD Journal of.

Metastatic pancreatic cancer masquerading as pulmonary sarcoidosis

Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD

A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient Jong Sik Lee, MD, Jae Young Hur, PhD,

Usual Interstitial Pneumonia Complicating Dyskeratosis Congenita

Sclerosing Pneumocytoma with Lymph Node Metastasis

Spontaneous regression of small cell lung cancer

Bronchiolitis Obliterans Organizing Pneumonia Due to Titanium Nanoparticles in Paint Tong-Hong Cheng, MD, Fu-Chang Ko, MD, Junn-Liang Chang, MD, Kuo-An.

David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F

A 67-Year-Old Man With Psoriatic Arthritis and New-Onset Dyspnea

Exogenous Lipoid Pneumonia Mimicking Multifocal Bronchogenic Carcinoma

Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Metastatic pancreatic cancer masquerading as pulmonary sarcoidosis

An Unusual Cause of Dysphagia with Bronchoesophageal Fistula

KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma Taylor M.

Treatment of Pulmonary Epithelioid Hemangioendothelioma with Bevacizumab Young Hak Kim, MD, Michiaki Mishima, MD, PhD, Aya Miyagawa-Hayashino, MD, PhD

Joline S. W. Lind, MBBS, Egbert F

Muhammad Umair Khawar, MD, Bhaskar Bhardwaj, MD, Himanshu Bhardwaj, MD

Patrick H. Archie, MD, Mary Beth Beasley, MD, Helen J. Ross, MD

Organizing Pneumonia Induced by Nivolumab in a Patient with Metastatic Melanoma Kazuhisa Nakashima, MD, Tateaki Naito, MD, Shota Omori, MD, Shusuke Yoshikawa,

An Unusual Presentation of Malignant Pleural Mesothelioma

Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease Satoru Yanagisawa, MD, PhD, Akira Inoue, MD, PhD, Akira Koarai, MD,

Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma Lih-Chyun Chang, MD, Kuan-Yu Chen, MD, PhD, Jin-Yuan.

Small Cell Transformation and T790M Mutation as Coresistance Mechanisms for First- line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor.

Atypical Pleuropulmonary Tuberculosis Mimicking a Malignant Disease

ALK and NRG1 Fusions Coexist in a Patient with Signet Ring Cell Lung Adenocarcinoma Lucia Anna Muscarella, PhD, Domenico Trombetta, PhD, Federico Pio.

A Case of Squamous Cell Carcinoma Harboring an EML4-ALK Rearrangement that Was Unsuccessfully Treated with the ALK Inhibitor Alectinib Akihiro Tamiya,

A Case of Invasive Mucinous Pulmonary Adenocarcinoma with a CD74-NRG1 Fusion Protein Targeted with Afatinib Parneet K. Cheema, MD, MBiotech, FRCPC Journal.

Multiple Pulmonary Chondroid Hamartoma

“Pseudoprogression” of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy Kentaro Ito, MD, Osamu Hataji, MD, Koji Katsuta, MD, Tetsu Kobayashi,

Pulmonary Blastoma with Renal Metastasis Responds to Sorafenib

Histologic Transformation in NSCLC with PD-1 therapy

Lung Metastases from Esophageal Granular Cell Tumor: An Undoubted Criterion for Malignancy Isidro Machado, MD, PhD, Julia Cruz, MD, PhD, Estanislao Arana,

Adnan M. Al-Ayoubi, MD, Jonathan S. Ralston, MD, S

Mark L. Kayton, MD, Mai He, MD, PhD, Maureen F. Zakowski, MD, Andre L

Lung Cancer Patients with Germline Mutations Detected by Next-Generation Sequencing and/or Liquid Biopsy Takehito Shukuya, MD, PhD, Sandipkumar Patel,

Complete Resection of Oligorecurrence of Stage I Lung Adenocarcinoma 19 Years After Operation Dai Sonoda, MD, Masashi Mikubo, MD, Kazu Shiomi, MD, PhD,

Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib Shiro Fujita, MD, PhD, Katsuhiro Masago, MD, PhD, Nobuyuki Katakami, MD, PhD,

Primary Malignant Pericardial Mesothelioma Mimicking Pericardial Metastasis from Adenocarcinoma Masafumi Horie, MD, Satoshi Noguchi, MD, Wakae Tanaka,

Solitary Choriocarcinoma in the Lung

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Jennifer L. Dallas, MD, Michael A. Jantz, MD, Judith L

Demonstration of persistent tumor cells 4 weeks after radiofrequency ablation of a pulmonary adenocarcinoma Stéphane Renaud, Marco Schiavon, MD, Nicola.

ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers Samuel J. Klempner, MD, David W. Cohen, MD, Daniel.

An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers Jules L. Derks, MD Journal of.

Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma Naoyuki.

Nivolumab-Induced Granulomatous Inflammation of the Pleura

Jeffrey Bradley, MD Journal of Thoracic Oncology

Niravkumar K. Sangani, MD, MCh, Santosh Mathew Naliath, MD, MCh

Multiple Pulmonary Nodules in an Elderly Woman

Anu Dham, MD, Alexander M. Truskinovsky, MD, Arkadiusz Z

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Concomitant Epidermal Growth Factor Receptor Mutation and EML4-ALK Fusion in a Patient with Multifocal Lung Adenocarcinomas Jun Fan, MD Journal of Thoracic.

Rituximab-Induced Acute Pulmonary Fibrosis

Ground-Glass Centrilobular Nodules on Multidetector CT Scan

Nonintubated thoracoscopic surgery for pulmonary lesions in both lungs

Cristiano Rampinelli, MD, Vittoria Vecchi, MD, Massimo Bellomi, MD

Journal of Thoracic Oncology

Successful Treatment with Pemetrexed in a Patient with Mucinous Bronchioloalveolar Carcinoma: Long-Term Response Duration with Mild Toxicity Chiyuki.

Robert Comis, MD, The Passing of a “Lung Man”

Presentation transcript:

Pulmonary Adenocarcinoma with Enteric Differentiation Presenting with Bronchorrhea Ritbune Prakobkit, MD, William Churk-Nam Auyeung, MD Journal of Thoracic Oncology Volume 12, Issue 8, Pages e120-e123 (August 2017) DOI: 10.1016/j.jtho.2017.04.005 Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 1 (A) Thoracic computed tomography scan demonstrating bilateral peripheral ground glass and consolidative opacities, with a dominant left lower lobe consolidation. (B) and (C) Lower lobe traction bronchiectasis and reticulation demonstrating pulmonary fibrosis. Journal of Thoracic Oncology 2017 12, e120-e123DOI: (10.1016/j.jtho.2017.04.005) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

Figure 2 (A) Scanning magnification of transthoracic lung biopsy specimen showing malignant glandular forms embedded in a fibroinflammatory stroma (hematoxylin and eosin; original magnification, ×100). (B) High-power magnification showing luminal necrotic debris within neoplastic glands (hematoxylin and eosin; original magnification, ×600). (C) Immunoreactivity for cytokeratin 7 (original magnification, ×200). (D) Focal positive staining for cytokeratin 20 (original magnification, ×200). (E) Strong diffuse nuclear staining with caudal type homeobox 2 (original magnification, ×200). (F) Positive staining for the lung marker thyroid transcription factor 1 (original magnification, ×200). Journal of Thoracic Oncology 2017 12, e120-e123DOI: (10.1016/j.jtho.2017.04.005) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions